IGF1R and neoplasm: Similar to most cancer types, IGF1R is targeted by miR-99a-5p and miR-100-5p in ESCC, resulting in the suppression of tumor cell proliferation, migration, invasion, and SLUG-induced EMT (Chen et al., 2023a; Mei et al., 2017).